Anne Arundel Medical Center in Maryland reduced opioid prescribing over a 16-month period by implementing interventions to educate prescribers, patients and the public about opioid risks and safety and promote clinician accountability, according to a study published Friday by JAMA Network Open. Monthly morphine milligram equivalents per encounter and MME per opioid prescription fell by 58 percent and 34 percent, respectively, compared with the average for the baseline period, while the opioid prescription rate fell by 38 percent. “Our data demonstrate that it is possible, through a coordinated, multilevel campaign, to reduce opioid overprescribing without worsening overall patient satisfaction,” the authors said. The AHA offers a toolkit to help hospitals and health systems work with their patients, clinicians and communities to tackle the opioid epidemic.

Related News Articles

Headline
Oct. 28 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and…
Headline
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from…
Headline
As the House Energy and Commerce Committee works to reauthorize key programs within the Substance Use-Disorder Prevention that Promotes Opioid Recovery and…
Headline
While counseling and other services are an important part of a comprehensive treatment plan for opioid use disorder, the provision of medication should not be…
Headline
AHA today launched an updated Opioid Stewardship Hub, featuring the latest tools and resources to help hospitals and health systems address the opioid epidemic…
Headline
The Food and Drug Administration last week required certain labeling updates for opioid pain medicines in an effort to reduce unnecessary prescribing and…